Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4I063
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.591 |
CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.500 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.664 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.556 |
CLV_PCSK_FUR_1 | 22 | 26 | PF00082 | 0.743 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.594 |
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.373 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.720 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.572 |
CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.373 |
CLV_PCSK_PC7_1 | 6 | 12 | PF00082 | 0.594 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.430 |
DOC_MAPK_gen_1 | 10 | 17 | PF00069 | 0.413 |
DOC_MAPK_MEF2A_6 | 10 | 17 | PF00069 | 0.427 |
DOC_MAPK_NFAT4_5 | 10 | 18 | PF00069 | 0.427 |
DOC_PP1_RVXF_1 | 73 | 80 | PF00149 | 0.294 |
LIG_14-3-3_CanoR_1 | 6 | 10 | PF00244 | 0.390 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.403 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.495 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.340 |
LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 80 | 89 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 80 | 84 | PF02991 | 0.385 |
LIG_Pex14_2 | 88 | 92 | PF04695 | 0.420 |
LIG_SH2_STAP1 | 139 | 143 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.481 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.315 |
LIG_UBA3_1 | 69 | 75 | PF00899 | 0.380 |
LIG_WRC_WIRS_1 | 89 | 94 | PF05994 | 0.383 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.761 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.634 |
MOD_N-GLC_1 | 25 | 30 | PF02516 | 0.695 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.412 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.436 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.481 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.360 |
MOD_PKA_2 | 5 | 11 | PF00069 | 0.398 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.597 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.331 |
TRG_DiLeu_BaEn_1 | 142 | 147 | PF01217 | 0.532 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.429 |
TRG_ER_diArg_1 | 154 | 156 | PF00400 | 0.700 |
TRG_ER_diArg_1 | 24 | 27 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 9 | 12 | PF00400 | 0.389 |
TRG_Pf-PMV_PEXEL_1 | 126 | 130 | PF00026 | 0.425 |
TRG_Pf-PMV_PEXEL_1 | 148 | 152 | PF00026 | 0.453 |
TRG_Pf-PMV_PEXEL_1 | 173 | 177 | PF00026 | 0.354 |
TRG_PTS2 | 1 | 35 | PF00400 | 0.421 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2Y2 | Leptomonas seymouri | 46% | 100% |
A0A0S4JFQ3 | Bodo saltans | 33% | 100% |
A0A3S7WXI2 | Leishmania donovani | 98% | 100% |
A4HCN8 | Leishmania braziliensis | 66% | 100% |
E9AW26 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q4QBF1 | Leishmania major | 90% | 100% |